Standard

Cognitive and affective disorders in ovarian cancer patients. / Petrova, N.; Belozer, A.

в: Psychiatry, Psychotherapy and Clinical Psychology, Том 10, № 3, 01.01.2019, стр. 451-460.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Petrova, N & Belozer, A 2019, 'Cognitive and affective disorders in ovarian cancer patients', Psychiatry, Psychotherapy and Clinical Psychology, Том. 10, № 3, стр. 451-460.

APA

Petrova, N., & Belozer, A. (2019). Cognitive and affective disorders in ovarian cancer patients. Psychiatry, Psychotherapy and Clinical Psychology, 10(3), 451-460.

Vancouver

Petrova N, Belozer A. Cognitive and affective disorders in ovarian cancer patients. Psychiatry, Psychotherapy and Clinical Psychology. 2019 Янв. 1;10(3):451-460.

Author

Petrova, N. ; Belozer, A. / Cognitive and affective disorders in ovarian cancer patients. в: Psychiatry, Psychotherapy and Clinical Psychology. 2019 ; Том 10, № 3. стр. 451-460.

BibTeX

@article{f778d16ba5474d3bb8175e1235444046,
title = "Cognitive and affective disorders in ovarian cancer patients",
abstract = "This review presents the results of the study of cognitive and effective functioning in ovarian cancer patients (OC). Ovarian cancer patients (N=82) were assessed at different stages of cancer treatment. Affective disorders were evaluated by means of HADS and MADRS; for assessment of cognitive domains, BACS was applied. The data analysis was completed by means of ANOVA, correlation and linear regression analysis. It was revealed that in OC patients, two cognitive domains are mostly impaired: motor functions (48%) and speed of data processing (46%). The results of linear regression analysis prove that cognitive impairments are caused by disease worsening (canceromatosis and FIGO stage). Statistically significant association between the amount of received chemo treatment and cognitive deficit was not revealed. Affective disorders (anxiety and depression) were present in 18% and 19.5% OC patients, respectively. Such disorders were present at all stages of the disease and caused by psychological and somatic factors. Anxiety and depression may play a mediating role in the development of cognitive impairments.",
keywords = "Affective disorders, Anxiety, Cognitive disorders, Depression, Neuropsychological diagnostics, Ovarian cancer, Psychooncology",
author = "N. Petrova and A. Belozer",
year = "2019",
month = jan,
day = "1",
language = "English",
volume = "10",
pages = "451--460",
journal = "Psychiatry, Psychotherapy and Clinical Psychology",
issn = "2220-1122",
publisher = "UE Professional Editions",
number = "3",

}

RIS

TY - JOUR

T1 - Cognitive and affective disorders in ovarian cancer patients

AU - Petrova, N.

AU - Belozer, A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This review presents the results of the study of cognitive and effective functioning in ovarian cancer patients (OC). Ovarian cancer patients (N=82) were assessed at different stages of cancer treatment. Affective disorders were evaluated by means of HADS and MADRS; for assessment of cognitive domains, BACS was applied. The data analysis was completed by means of ANOVA, correlation and linear regression analysis. It was revealed that in OC patients, two cognitive domains are mostly impaired: motor functions (48%) and speed of data processing (46%). The results of linear regression analysis prove that cognitive impairments are caused by disease worsening (canceromatosis and FIGO stage). Statistically significant association between the amount of received chemo treatment and cognitive deficit was not revealed. Affective disorders (anxiety and depression) were present in 18% and 19.5% OC patients, respectively. Such disorders were present at all stages of the disease and caused by psychological and somatic factors. Anxiety and depression may play a mediating role in the development of cognitive impairments.

AB - This review presents the results of the study of cognitive and effective functioning in ovarian cancer patients (OC). Ovarian cancer patients (N=82) were assessed at different stages of cancer treatment. Affective disorders were evaluated by means of HADS and MADRS; for assessment of cognitive domains, BACS was applied. The data analysis was completed by means of ANOVA, correlation and linear regression analysis. It was revealed that in OC patients, two cognitive domains are mostly impaired: motor functions (48%) and speed of data processing (46%). The results of linear regression analysis prove that cognitive impairments are caused by disease worsening (canceromatosis and FIGO stage). Statistically significant association between the amount of received chemo treatment and cognitive deficit was not revealed. Affective disorders (anxiety and depression) were present in 18% and 19.5% OC patients, respectively. Such disorders were present at all stages of the disease and caused by psychological and somatic factors. Anxiety and depression may play a mediating role in the development of cognitive impairments.

KW - Affective disorders

KW - Anxiety

KW - Cognitive disorders

KW - Depression

KW - Neuropsychological diagnostics

KW - Ovarian cancer

KW - Psychooncology

UR - http://www.scopus.com/inward/record.url?scp=85074092779&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85074092779

VL - 10

SP - 451

EP - 460

JO - Psychiatry, Psychotherapy and Clinical Psychology

JF - Psychiatry, Psychotherapy and Clinical Psychology

SN - 2220-1122

IS - 3

ER -

ID: 48634275